Influence of human sera on the in vitro activity of the echinocandin caspofungin (MK-0991) against Aspergillus fumigatus
- PMID: 11083631
- PMCID: PMC90196
- DOI: 10.1128/AAC.44.12.3302-3305.2000
Influence of human sera on the in vitro activity of the echinocandin caspofungin (MK-0991) against Aspergillus fumigatus
Abstract
There have been several reports that the activity of echinocandin antifungal agents is not affected or decreased in the presence of human sera. It is known that these drugs are bound >80% in animal and human sera. The activity of the echinocandin caspofungin (MK-0991), a 1,3-beta-D-glucan synthase inhibitor, against Aspergillus fumigatus with and without human sera was studied. Conidia of A. fumigatus in microtest plate wells formed germlings after overnight culture in RPMI 1640. Caspofungin was then added with or without serum, and the germlings were incubated at 37 degrees C for 24 h. Human serum (5%) in RPMI 1640 alone did not significantly inhibit the growth of A. fumigatus in vitro. Caspofungin in RPMI 1640 exhibited dose-dependent inhibition, with concentrations of 0.1 and 0.05 microg/ml inhibiting 24.9% +/- 10.4% and 11.7% +/- 3.6%, respectively (n = 10; P < 0.01). The addition of 5% human serum to caspofungin at 0.1 or 0.05 microg/ml increased the inhibition to 78.6% +/- 5.8% or 58.3% +/- 19.2%, respectively (n = 10; P < 0.01 versus controls and versus the drug without serum). Lower concentrations of serum also potentiated drug activity. The effect of human sera was further seen when using caspofungin that had lost activity (e.g., by storage) against A. fumigatus at 0.1 microg/ml. Inactive caspofungin alone demonstrated no significant inhibition of hyphal growth, whereas the addition of 5% human serum to the inactive drug showed 83% +/- 16.5% inhibition (n = 5; P < 0. 01). The restoration of activity of caspofungin was seen at concentrations as low as 0.05% human serum. In contrast to prior reports, this study suggests that human serum acts synergistically with caspofungin to enhance its inhibitory activity in vitro against A. fumigatus.
Figures
Similar articles
-
The interaction of human monocytes, monocyte-derived macrophages, and polymorphonuclear neutrophils with caspofungin (MK-0991), an echinocandin, for antifungal activity against Aspergillus fumigatus.Diagn Microbiol Infect Dis. 2001 Feb;39(2):99-103. doi: 10.1016/s0732-8893(00)00236-4. Diagn Microbiol Infect Dis. 2001. PMID: 11248522
-
The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro.Antimicrob Agents Chemother. 2002 Sep;46(9):3001-12. doi: 10.1128/AAC.46.9.3001-3012.2002. Antimicrob Agents Chemother. 2002. PMID: 12183260 Free PMC article.
-
Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.Antimicrob Agents Chemother. 2008 Jan;52(1):321-8. doi: 10.1128/AAC.00699-07. Epub 2007 Oct 15. Antimicrob Agents Chemother. 2008. PMID: 17938191 Free PMC article.
-
Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin.Med Mycol. 2005 May;43 Suppl 1:S299-305. doi: 10.1080/13693780400029023. Med Mycol. 2005. PMID: 16110824 Review.
-
Caspofungin: an echinocandin antifungal agent.Clin Ther. 2002 Mar;24(3):351-77; discussion 329. doi: 10.1016/s0149-2918(02)85039-1. Clin Ther. 2002. PMID: 11952021 Review.
Cited by
-
Effects of serum on in vitro susceptibility testing of echinocandins.Antimicrob Agents Chemother. 2007 Nov;51(11):4214-6. doi: 10.1128/AAC.01589-06. Epub 2007 Sep 4. Antimicrob Agents Chemother. 2007. PMID: 17785512 Free PMC article.
-
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera.Antimicrob Agents Chemother. 2007 May;51(5):1616-20. doi: 10.1128/AAC.00105-07. Epub 2007 Feb 16. Antimicrob Agents Chemother. 2007. PMID: 17307976 Free PMC article.
-
Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii.Antimicrob Agents Chemother. 2006 Aug;50(8):2829-32. doi: 10.1128/AAC.00524-06. Antimicrob Agents Chemother. 2006. PMID: 16870779 Free PMC article.
-
Susceptibility of Pneumocystis to echinocandins in suspension and biofilm cultures.Antimicrob Agents Chemother. 2011 Oct;55(10):4513-8. doi: 10.1128/AAC.00017-11. Epub 2011 Jul 25. Antimicrob Agents Chemother. 2011. PMID: 21788469 Free PMC article.
-
Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation.Antimicrob Agents Chemother. 2003 Jun;47(6):1818-23. doi: 10.1128/AAC.47.6.1818-1823.2003. Antimicrob Agents Chemother. 2003. PMID: 12760853 Free PMC article.
References
-
- Abruzzo G K, Flattery A M, Gill C J, Kong L, Smith J G, Pikounis V B, Balkovec J M, Bouffard A F, Dropinski J F, Rosen H, Kropp H, Bartizal K. Evaluation of the echinocandin antifungal caspofungin (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother. 1997;41:2333–2338. - PMC - PubMed
-
- Brummer E, Chauhan S D, Stevens D A. Collaboration of human phagocytes with LY 303366 for antifungal activity against Aspergillus fumigatus. J Antimicrob Chemother. 1999;43:491–496. - PubMed
-
- Brummer E, Kamei K, Miyaji M. Anticryptococcal activity of voriconazole against Cryptococcus var. gattii vs. var. neoformans; comparison with fluconazole and effect of human serum. Mycopathology. 1998;142:3–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical